Quest Diagnostics
DGX · NYSE
Bulios Fair Price
$294.55
26.3% upside
Trenutna cena
$233.24
Po podatkih Bulios Fair Price je delnica DGX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Quest Diagnostics Incorporated (DGX) is an American company that provides diagnostic information and services for healthcare. The company offers a wide range of laboratory tests and diagnostic services, including blood tests, genetic tests, tests for infectious diseases, and screening tests for disease prevention. With an extensive network of laboratories and partnerships with healthcare providers, Quest Diagnostics is one of the leading providers of diagnostic services in the United States. The company is known for its quality, reliability, and ability to provide comprehensive diagnostic information for physicians and patients. Quest Diagnostics Incorporated (DGX) shares could be suitable for investors looking to invest in companies providing healthcare services and diagnostic information with a strong market position and a good reputation in the healthcare industry.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis
Employees
51,500
Headquarters
Secaucus
Prihajajoči dogodki
Ex-Dividend
Ex-dividend date
Dividend Payment
Datum plačila
Earnings
Upcoming earnings report